Form 4 for EW Edwards Lifesciences
Accepted 2022-11-14 00:00:00 ET · period of report 2022-11-14 · accession 0001225208-22-011662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-14 | 2022-11-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $74.15 | -19.9K | 182.4K | -10% | -$1.47M |
| D | 2022-11-14 | 2022-11-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $35.20 | +29.4K | 186.7K | +19% | +$1.03M |
| DI | 2022-11-14 | 2022-11-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +9,500 | 3.46M | +0.3% | $0 |
| D | 2022-11-14 | 2022-11-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -9,500 | 172.9K | -5% | $0 |
| D | 2022-11-14 | 2022-11-14 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $0.00 | -29.4K | 176.2K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-14 | S | D | 200 | $75.47 | 186,527.82 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-14 | M | A | 29,375 | $35.20 | 186,727.82 | D By Living Trust | — | — | |
| 3 | Common | Common Stock | 2022-11-14 | G | A | 9,500 | $0.00 | 3,463,517 | I | — | — | |
| 4 | Common | Common Stock | 2022-11-14 | S | D | 15,575 | $73.94 | 157,352.82 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $73.40 to $74.39 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2022-11-14 | G | D | 9,500 | $0.00 | 172,927.82 | D | — | — | |
| 6 | Common | Common Stock | 2022-11-14 | S | D | 4,100 | $74.86 | 182,427.82 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $74.41 to $75.41 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Derivative | Employee Stock Option (Right to Acquire) | 2022-11-14 | M | D | 29,375 | $0.00 | 176,250 | D | $35.20 · 2016-06-12 to 2023-05-11 | 29,375 Common Stock |